Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN-BLMF vs BELUMOSUDIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN-BLMF vs BELUMOSUDIL: Safety Overview

Metric BELANTAMAB MAFODOTIN-BLMF BELUMOSUDIL
Total FAERS Reports 150 2,604
Deaths Reported 60 223
Death Rate 40.0% 8.6%
Hospitalizations 36 700
Average Patient Age 65.9 yrs 54.3 yrs
% Female Patients 48.3% 46.7%
FDA Approval Date N/A Jul 16, 2021
Manufacturer N/A Kadmon Pharmaceuticals, LLC
Route N/A ORAL
Marketing Status Prescription Prescription